Skip to main content
SpringerLink
Log in

Hyperkinetic Disorders in Childhood

  • Chapter
Hyperkinetic Movement Disorders

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Movement disorders in children are symptoms that can be caused by many different diseases. Movement disorders are typically classified into primary and secondary disorders [1]. Primary movement disorders are conditions in which the movement disorder is the major symptom of a genetic or presumed genetic disorder. Secondary movement disorders are conditions in which the movement disorder is an expression of an underlying disease that may include other signs and symptoms, and which may be due to an acquired injury, infection, toxin, or metabolic process. Most movement disorders in children are secondary. One of the particular complicating factors of movement disorders in childhood is that several different disorders may coexist in the same child, making diagnosis difficult. In addition, many different etiologies can lead to the same disorder, and the same etiology can lead to different movement disorders in different children, or in the same child at a different age. Nevertheless, a thorough understanding of the different types of movement disorder, their possible causes, and the different types of expression that may occur in children is essential to guiding clinical practice for both diagnosis and effective treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sanger TD. Pediatric movement disorders. Curr Opin Neurol. 2003;16(4):529–35.

    PubMed  Google Scholar 

  2. Sanger TD, et al. Definition and classification of negative motor signs in childhood. Pediatrics. 2006;118:2159–67.

    Article  PubMed  Google Scholar 

  3. Sanger TD, et al. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 2003;111(1):e89–97.

    Article  PubMed  Google Scholar 

  4. Sanger TD, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25(11):1538–49.

    Article  PubMed  Google Scholar 

  5. Ramos E, et al. Quantification of upper extremity function using kinematic analysis. Arch Phys Med Rehabil. 1997;78(5):491–6.

    Article  PubMed  CAS  Google Scholar 

  6. Bastian AJ, et al. Cerebellar ataxia: abnormal control of interaction torques across multiple joints. J Neurophysiol. 1996;76(1):492–509.

    PubMed  CAS  Google Scholar 

  7. Bastian AJ, Zackowski KM, Thach WT. Cerebellar ataxia: torque deficiency or torque mismatch between joints? J Neurophysiol. 2000;83(5):3019–30.

    PubMed  CAS  Google Scholar 

  8. Bastian AJ. Cerebellar limb ataxia: abnormal control of self-generated and external forces. Ann N Y Acad Sci. 2002;978:16–27.

    Article  PubMed  Google Scholar 

  9. Michaelsen SM, et al. Compensation for distal impairments of grasping in adults with hemiparesis. Exp Brain Res. 2004;157(2):162–73.

    Article  PubMed  Google Scholar 

  10. Flowers KA. Visual “closed-loop” and “open-loop” characteristics of voluntary movement in patients with Parkinsonism and intention tremor. Brain. 1976;99(2):269–310.

    Article  PubMed  CAS  Google Scholar 

  11. Feys P, et al. The effect of changed visual feedback on intention tremor in multiple sclerosis. Neurosci Lett. 2006;394(1):17–21.

    Article  PubMed  CAS  Google Scholar 

  12. Campbell SK. Quantifying the effects of interventions for movement disorders resulting from cerebral palsy. J Child Neurol. 1996;11 Suppl 1:S61–70.

    PubMed  Google Scholar 

  13. Lollar DJ, Simeonsson RJ, Nanda U. Measures of outcomes for children and youth. Arch Phys Med Rehabil. 2000;81(12 Suppl 2):S46–52.

    Article  PubMed  CAS  Google Scholar 

  14. World Health Organization. Towards a common language for functioning, disability, and health: The International Classification of Functioning, Disability, and Health (ICF). Geneva: World Health Organization; 2002.

    Google Scholar 

  15. Marsden CD, Obeso JA, Rothwell JC. Clinical neurophysiology of muscle jerks: myoclonus, chorea, and tics. Adv Neurol. 1983;39:865–81.

    PubMed  CAS  Google Scholar 

  16. Higgins DS Jr. Chorea and its disorders. Neurol Clin. 2001;19(3):707–22, vii.

    Google Scholar 

  17. Levy EJ, et al. Kinematics of chorea in Huntington disease. Soc Neurosci. 2003:SFN.

    Google Scholar 

  18. Bhidayasiri R, Truong DD. Chorea and related disorders. Postgrad Med J. 2004;80(947):527–34.

    Article  PubMed  CAS  Google Scholar 

  19. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366–75.

    Article  PubMed  CAS  Google Scholar 

  20. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13:281–5.

    Article  PubMed  CAS  Google Scholar 

  21. Tian JR, et al. Postural control in Huntington’s disease (HD). Acta Otolaryngol Suppl. 1991;481:333–6.

    Article  PubMed  CAS  Google Scholar 

  22. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9(5):493–507.

    Article  PubMed  CAS  Google Scholar 

  23. Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends Neurosci. 1995;18(2):63–4.

    Article  PubMed  CAS  Google Scholar 

  24. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol. 1996;6:751–8.

    Article  PubMed  CAS  Google Scholar 

  25. Church AJ, et al. Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology. 2002;59(2):227–31.

    Article  PubMed  CAS  Google Scholar 

  26. Martino D, Giovannoni G. Antibasal ganglia antibodies and their relevance to movement disorders. Curr Opin Neurol. 2004;17(4):425–32.

    Article  PubMed  Google Scholar 

  27. Wang HS, et al. Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatr Neurol. 1994;11(4):341–5.

    Article  PubMed  CAS  Google Scholar 

  28. Gascon GG, et al. Chorea as a presentation of herpes simplex encephalitis relapse. Brain Dev. 1993;15(3):178–81.

    Article  PubMed  CAS  Google Scholar 

  29. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst). 2004;3(8–9):1187–96.

    Article  CAS  Google Scholar 

  30. Tranchant C, et al. Phenotypic variability of aprataxin gene mutations. Neurology. 2003;60(5):868–70.

    Article  PubMed  CAS  Google Scholar 

  31. Shimazaki H, et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations. Neurology. 2002;59(4):590–5.

    Article  PubMed  CAS  Google Scholar 

  32. Moreira MC, et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet. 2001;29(2):189–93.

    Article  PubMed  CAS  Google Scholar 

  33. Danek A, et al. Neuroacanthocytosis: new developments in a neglected group of dementing disorders. J Neurol Sci. 2005;229–230:171–86.

    Article  PubMed  Google Scholar 

  34. Jinnah HA, et al. Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 2006;129(Pt 5):1201–17.

    Article  PubMed  CAS  Google Scholar 

  35. Marson AM, et al. Neuroacanthocytosis: clinical, radiological, and neurophysiological findings in an Italian family. Neurol Sci. 2003;24(3):188–9.

    Article  PubMed  CAS  Google Scholar 

  36. Breedveld GJ, et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet. 2002;11(8):971–9.

    Article  PubMed  CAS  Google Scholar 

  37. Quinn N, Schrag A. Huntington’s disease and other choreas. J Neurol. 1998;245(11):709–16.

    Article  PubMed  CAS  Google Scholar 

  38. Topper R, et al. Neurophysiological abnormalities in the Westphal variant of Huntington’s disease. Mov Disord. 1998;13(6):920–8.

    Article  PubMed  CAS  Google Scholar 

  39. Tost H, et al. Huntington’s disease: phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry. Am J Psychiatry. 2004;161(1):28–34.

    Article  PubMed  Google Scholar 

  40. Jordan LC, Singer HS. Sydenham chorea in children. Curr Treat Options Neurol. 2003;5(4):283–90.

    Article  PubMed  Google Scholar 

  41. Jummani R, Okun M. Sydenham chorea. Arch Neurol. 2001;58(2):311–3.

    Article  PubMed  CAS  Google Scholar 

  42. Garvey MA, Swedo SE. Sydenham’s chorea. Clinical and therapeutic update. Adv Exp Med Biol. 1997;418:115–20.

    PubMed  CAS  Google Scholar 

  43. Hayflick SJ, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med. 2003;348(1):33–40.

    Article  PubMed  CAS  Google Scholar 

  44. Hayflick SJ, et al. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol. 2006;27(6):1230–3.

    PubMed  CAS  Google Scholar 

  45. Zolkipli Z, et al. Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without ‘eye-of-the-tiger’ sign on MRI in a pair of siblings. Pediatr Radiol. 2006;36(8):884–6.

    Article  PubMed  Google Scholar 

  46. Danek A, Walker RH. Neuroacanthocytosis. Curr Opin Neurol. 2005;18(4):386–92.

    Article  PubMed  Google Scholar 

  47. Storch A, Kornhass M, Schwarz J. Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients. J Neurol. 2005;252(1):84–90.

    Article  PubMed  Google Scholar 

  48. Chatterjee A, Frucht SJ. Tetrabenazine in the treatment of severe pediatric chorea. Mov Disord. 2003;18(6):703–6.

    Article  PubMed  Google Scholar 

  49. Asher SW, Aminoff MJ. Tetrabenazine and movement disorders. Neurology. 1981;31(8):1051–4.

    Article  PubMed  CAS  Google Scholar 

  50. Ondo WG, et al. Tetrabenazine treatment for Huntington’s disease-associated chorea. Clin Neuropharmacol. 2002;25(6):300–2.

    Article  PubMed  CAS  Google Scholar 

  51. Grove Jr VE, Quintanilla J, DeVaney GT. Improvement of Huntington’s disease with olanzapine and valproate. N Engl J Med. 2000;343(13):973–4.

    Article  PubMed  Google Scholar 

  52. Pena J, et al. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham’s chorea: clinical follow-up of 18 patients. Arq Neuropsiquiatr. 2002;60(2-B):374–7.

    Article  PubMed  Google Scholar 

  53. Genel F, et al. Sydenham’s chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 2002;24(2):73–6.

    Article  PubMed  Google Scholar 

  54. Kulkarni ML, Anees S. Sydenham’s chorea. Indian Pediatr. 1996;33(2):112–5.

    PubMed  CAS  Google Scholar 

  55. Thompson PD, et al. Cortical myoclonus in Huntington’s disease. Mov Disord. 1994;9(6):633–41.

    Article  PubMed  CAS  Google Scholar 

  56. Recio MV, et al. Chorea in a patient with cerebral palsy: treatment with levetiracetam. Mov Disord. 2005;20(6):762–4.

    Article  PubMed  Google Scholar 

  57. Destee A, Petit H, Warot P. Effect of piracetam in Huntington’s chorea. Eur Neurol. 1984;23(2):89–91.

    Article  PubMed  CAS  Google Scholar 

  58. Bonelli RM, Wenning GK. Pharmacological management of Huntington’s disease: an evidence-based review. Curr Pharm Des. 2006;12(21):2701–20.

    Article  PubMed  CAS  Google Scholar 

  59. Gebremariam A. Sydenham’s chorea: risk factors and the role of prophylactic benzathine penicillin G in preventing recurrence. Ann Trop Paediatr. 1999;19(2):161–5.

    Article  PubMed  CAS  Google Scholar 

  60. Moore DP. Neuropsychiatric aspects of Sydenham’s chorea: a comprehensive review. J Clin Psychiatry. 1996;57(9):407–14.

    PubMed  CAS  Google Scholar 

  61. Wilcox JA, Nasrallah H. Sydenham’s chorea and psychopathology. Neuropsychobiology. 1988;19(1):6–8.

    Article  PubMed  CAS  Google Scholar 

  62. March JS. Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection (PANDAS): implications for clinical practice. Arch Pediatr Adolesc Med. 2004;158(9):927–9.

    Article  PubMed  Google Scholar 

  63. Trifiletti RR, Packard AM. Immune mechanisms in pediatric neuropsychiatric disorders. Tourette’s syndrome, OCD, and PANDAS. Child Adolesc Psychiatr Clin N Am. 1999;8(4):767–75.

    PubMed  CAS  Google Scholar 

  64. Snider LA, Swedo SE. PANDAS: current status and directions for research. Mol Psychiatry. 2004;9(10):900–7.

    Article  PubMed  CAS  Google Scholar 

  65. Chmelik E, et al. Varied presentation of PANDAS: a case series. Clin Pediatr (Phila). 2004;43(4):379–82.

    Article  Google Scholar 

  66. Pavone P, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol. 2004;30(2):107–10.

    Article  PubMed  Google Scholar 

  67. Swedo SE. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry. 2002;7 Suppl 2:S24–5.

    Article  PubMed  Google Scholar 

  68. Green LN. Corticosteroids in the treatment of Sydenham’s chorea. Arch Neurol. 1978;35(1):53–4.

    Article  PubMed  CAS  Google Scholar 

  69. Cardoso F, et al. Treatment of Sydenham chorea with corticosteroids. Mov Disord. 2003;18(11):1374–7.

    Article  PubMed  Google Scholar 

  70. Albanese A. The clinical expression of primary dystonia. J Neurol. 2003;250(10):1145–51.

    Article  PubMed  Google Scholar 

  71. Marsden CD. The pathophysiology of movement disorders. Neurol Clin. 1984;2(3):435–59.

    PubMed  CAS  Google Scholar 

  72. Malfait N, Sanger TD. Does dystonia always include co-contraction? A study of unconstrained reaching in children with primary and secondary dystonia. Exp Brain Res. 2007;176(2):206–16.

    Google Scholar 

  73. Putzki N, et al. Kinesthesia is impaired in focal dystonia. Mov Disord. 2006;21(6):754–60.

    Article  PubMed  Google Scholar 

  74. Frima N, Rome SM, Grunewald RA. The effect of fatigue on abnormal vibration induced illusion of movement in idiopathic focal dystonia. J Neurol Neurosurg Psychiatry. 2003;74(8):1154–6.

    Article  PubMed  CAS  Google Scholar 

  75. Rome S, Grunewald RA. Abnormal perception of vibration-induced illusion of movement in dystonia. Neurology. 1999;53(8):1794–800.

    Article  PubMed  CAS  Google Scholar 

  76. Blake DT, et al. Sensory representation abnormalities that parallel focal hand dystonia in a primate model. Somatosens Mot Res. 2002;19(4):347–57.

    Article  PubMed  Google Scholar 

  77. McKenzie AL, et al. Somatosensory representation of the digits and clinical performance in patients with focal hand dystonia. Am J Phys Med Rehabil. 2003;82(10):737–49.

    Article  PubMed  CAS  Google Scholar 

  78. Sanger TD, et al. Nonlinear sensory cortex response to simultaneous tactile stimuli in writer’s cramp. Mov Disord. 2002;17(1):105–11.

    Article  PubMed  Google Scholar 

  79. Sanger TD, Tarsy D, Pascual-Leone A. Abnormalities of spatial and temporal sensory discrimination in writer’s cramp. Mov Disord. 2001;16(1):94–9.

    Article  PubMed  CAS  Google Scholar 

  80. Goyal V, Behari M. Dystonia as presenting manifestation of ataxia telangiectasia: a case report. Neurol India. 2002;50(2):187–9.

    PubMed  CAS  Google Scholar 

  81. Woods CG, Taylor AM. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med. 1992;82(298):169–79.

    PubMed  CAS  Google Scholar 

  82. Vitek JL. Pathophysiology of dystonia: a neuronal model. Mov Disord. 2002;17 Suppl 3:S49–62.

    Article  PubMed  Google Scholar 

  83. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol. 1996;50:381–425.

    Article  PubMed  CAS  Google Scholar 

  84. Segawa M, Nishiyama N, Nomura Y. DOPA-responsive dystonic parkinsonism–pathophysiologic considerations. Adv Neurol. 1999;80:389–400.

    PubMed  CAS  Google Scholar 

  85. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol. 2003;54 Suppl 6:S32–45.

    Article  PubMed  CAS  Google Scholar 

  86. Bressman SB, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 2000;54(9):1746–52.

    Article  PubMed  CAS  Google Scholar 

  87. Kabakci K, et al. Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology. 2004;62(3):395–400.

    Article  PubMed  CAS  Google Scholar 

  88. Cif L, et al. Treatment of dystonic syndromes by chronic electrical stimulation of the internal globus pallidus. J Neurosurg Sci. 2003;47(1):52–5.

    PubMed  CAS  Google Scholar 

  89. Krause M, et al. Pallidal stimulation for dystonia. Neurosurgery. 2004;55(6):1361–8, discussion 1368–70.

    Google Scholar 

  90. Coubes P, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg. 2004;101(2):189–94.

    Article  PubMed  Google Scholar 

  91. Kyllerman M. Dyskinetic cerebral palsy. II. Pathogenetic risk factors and intra-uterine growth. Acta Paediatr Scand. 1982;71(4):551–8.

    Article  PubMed  CAS  Google Scholar 

  92. Krageloh-Mann I, et al. Bilateral lesions of thalamus and basal ganglia: origin and outcome. Dev Med Child Neurol. 2002;44(7):477–84.

    Article  PubMed  Google Scholar 

  93. Volpe JJ. Neurology of the newborn. 4th ed. Philadelphia: WB Saunders; 2000.

    Google Scholar 

  94. Bhutani VK, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24(10):650–62.

    Article  PubMed  Google Scholar 

  95. Rubaltelli FF. Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus. Drugs. 1998;56(1):23–30.

    Article  PubMed  CAS  Google Scholar 

  96. Blackmon LR, Fanaroff AA, Raju TN. Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development conference executive summary. 2003. Pediatrics. 2004;114(1):229–33.

    Article  PubMed  Google Scholar 

  97. Stevenson DK, et al. NICHD Conference on Kernicterus: Research on prevention of bilirubin-induced brain injury and kernicterus: bench-to-bedside–diagnostic methods and prevention and treatment strategies. J Perinatol. 2004;24(8):521–5.

    Article  PubMed  Google Scholar 

  98. Govaert P, et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics. 2003;112(6 Pt 1):1256–63.

    Article  PubMed  Google Scholar 

  99. Johnston MV, Hoon Jr AH. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol. 2000;15(9):588–91.

    Article  PubMed  CAS  Google Scholar 

  100. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. 2005;25(1):54–9.

    Article  PubMed  CAS  Google Scholar 

  101. Opal P, et al. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002;17(2):339–45.

    Article  PubMed  Google Scholar 

  102. Dalvi A, Fahn S, Ford B. Intrathecal baclofen in the treatment of dystonic storm. Mov Disord. 1998;13(3):611–2.

    Article  PubMed  CAS  Google Scholar 

  103. Kyriagis M, et al. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health. 2004;40(5–6):322–5.

    Article  PubMed  CAS  Google Scholar 

  104. Angelini L, et al. Life-threatening dystonia-dyskinesias in a child: successful treatment with bilateral pallidal stimulation. Mov Disord. 2000;15(5):1010–2.

    Article  PubMed  CAS  Google Scholar 

  105. Pourcher E, et al. Neuroleptic associated tardive dyskinesias in young people with psychoses. Br J Psychiatry. 1995;166(6):768–72.

    Article  PubMed  CAS  Google Scholar 

  106. Burke RE, et al. Tardive dystonia and inappropriate use of neuroleptic drugs. Lancet. 1982;1(8284):1299.

    Article  PubMed  CAS  Google Scholar 

  107. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol. 1988;50:377–84.

    PubMed  CAS  Google Scholar 

  108. Klein C, et al. Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test. 1999;3(4):323–8.

    Article  PubMed  CAS  Google Scholar 

  109. O’Riordan S, et al. Age at onset as a factor in determining the phenotype of primary torsion dystonia. Neurology. 2004;63(8):1423–6.

    Article  PubMed  Google Scholar 

  110. Bandmann O, Wood NW. Dopa-responsive dystonia—the story so far. Neuropediatrics. 2002;33(1):1–5.

    Article  PubMed  CAS  Google Scholar 

  111. Nyhan WL. Clinical features of the Lesch-Nyhan syndrome. Introduction–clinical and genetic features. Fed Proc. 1968;27(4):1027–33.

    PubMed  CAS  Google Scholar 

  112. Nyhan WL. Lesch-Nyhan syndrome. Summary of clinical features. Fed Proc. 1968;27(4):1034–41.

    PubMed  CAS  Google Scholar 

  113. Nyhan WL. Clinical features of the Lesch-Nyhan syndrome. Arch Intern Med. 1972;130(2):186–92.

    Article  PubMed  CAS  Google Scholar 

  114. Sheehy EC, et al. Self-inflicted injury in a case of Hallervorden-Spatz disease. Int J Paediatr Dent. 1999;9(4):299–302.

    Article  PubMed  CAS  Google Scholar 

  115. Hallett M. Analysis of abnormal voluntary and involuntary movements with surface electromyography. Adv Neurol. 1983;39:907–14.

    PubMed  CAS  Google Scholar 

  116. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol. 1988;50:431–55.

    PubMed  CAS  Google Scholar 

  117. Thomas M, Jankovic J. Psychogenic movement disorders: diagnosis and management. CNS Drugs. 2004;18(7):437–52.

    Article  PubMed  Google Scholar 

  118. Kirsch DB, Mink JW. Psychogenic movement disorders in children. Pediatr Neurol. 2004;30(1):1–6.

    Article  PubMed  Google Scholar 

  119. Ozekmekci S, et al. Psychogenic movement disorders in two children. Mov Disord. 2003;18(11):1395–7.

    Article  PubMed  Google Scholar 

  120. Pringsheim T, Lang AE. Psychogenic dystonia. Rev Neurol (Paris). 2003;159(10 Pt 1):885–91.

    CAS  Google Scholar 

  121. Miyasaki JM, et al. Psychogenic movement disorders. Can J Neurol Sci. 2003;30 Suppl 1:S94–100.

    PubMed  Google Scholar 

  122. Feinstein A, et al. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(3):169–76.

    PubMed  CAS  Google Scholar 

  123. Bentivoglio AR, et al. Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia? Mov Disord. 2002;17(5):1058–63.

    Article  PubMed  Google Scholar 

  124. Bandmann O, et al. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet. 1996;5(3):403–6.

    Article  PubMed  CAS  Google Scholar 

  125. Bandmann O, et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol. 1998;44(4):649–56.

    Article  PubMed  CAS  Google Scholar 

  126. Furukawa Y, et al. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol. 2000;47(4):517–20.

    Article  PubMed  CAS  Google Scholar 

  127. Hwang WJ, et al. The long-term response to levodopa in dopa-responsive dystonia. Parkinsonism Relat Disord. 2001;8(1):1–5.

    Article  PubMed  CAS  Google Scholar 

  128. Nutt JG, Nygaard TG. Response to levodopa treatment in dopa-responsive dystonia. Arch Neurol. 2001;58(6):905–10.

    Article  PubMed  CAS  Google Scholar 

  129. Brunstrom JE, et al. Motor benefit from levodopa in spastic quadriplegic cerebral palsy. Ann Neurol. 2000;47(5):662–5.

    Article  PubMed  CAS  Google Scholar 

  130. Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology. 1986;36(2):160–4.

    Article  PubMed  CAS  Google Scholar 

  131. Hoon Jr AH, et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol. 2001;25(1):55–8.

    Article  PubMed  Google Scholar 

  132. Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol. 2007;22(5):530–7.

    Article  PubMed  Google Scholar 

  133. Roach ES, et al. Carbamazepine trial for Lesch-Nyhan self-mutilation. J Child Neurol. 1996;11(6):476–8.

    Article  PubMed  CAS  Google Scholar 

  134. Saito Y, Takashima S. Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain Dev. 2000;22 Suppl 1:S122–31.

    Article  PubMed  Google Scholar 

  135. Cusumano FJ, Penna KJ, Panossian G. Prevention of self-mutilation in patients with Lesch-Nyhan syndrome: review of literature. ASDC J Dent Child. 2001;68(3):175–8.

    PubMed  CAS  Google Scholar 

  136. Swash M, et al. Treatment of involuntary movement disorders with tetrabenazine. J Neurol Neurosurg Psychiatry. 1972;35(2):186–91.

    Article  PubMed  CAS  Google Scholar 

  137. Jankovic J, et al. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol. 1988;23(5):466–9.

    Article  PubMed  CAS  Google Scholar 

  138. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord. 1986;1(3):193–208.

    Article  PubMed  CAS  Google Scholar 

  139. Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Eur J Neurol. 2001;8 Suppl 5:150–66.

    Article  PubMed  Google Scholar 

  140. Graham HK, Boyd RN, Fehlings D. Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy? Med J Aust. 2003;178(2):95–6.

    PubMed  Google Scholar 

  141. Ozelius LJ, et al. The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics. 1999;62(3):377–84.

    Article  PubMed  CAS  Google Scholar 

  142. Bressman SB, et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol. 1994;36(5):771–7.

    Article  PubMed  CAS  Google Scholar 

  143. Coubes P, et al. Treatment of dystonia syndrome by chronic electric stimulation of the internal globus pallidus. Arch Pediatr. 2002;9 Suppl 2:84s–6.

    Article  PubMed  Google Scholar 

  144. Krack P, Vercueil L. Review of the functional surgical treatment of dystonia. Eur J Neurol. 2001;8(5):389–99.

    Article  PubMed  CAS  Google Scholar 

  145. Teive HA, et al. Bilateral pallidotomy for generalized dystonia. Arq Neuropsiquiatr. 2001;59(2-B):353–7.

    Article  PubMed  CAS  Google Scholar 

  146. Albright AL, et al. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery. 1996;38(5):934–8, discussion 938–9.

    Google Scholar 

  147. Albright AL, et al. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg. 1998;88(1):73–6.

    Article  PubMed  CAS  Google Scholar 

  148. Albright AL, et al. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43(10):652–7.

    Article  PubMed  CAS  Google Scholar 

  149. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel. Dev Med Child Neurol. 2000;42(9):634–45.

    Article  PubMed  CAS  Google Scholar 

  150. Ford B, et al. Intrathecal baclofen in the treatment of dystonia. Adv Neurol. 1998;78:199–210.

    PubMed  CAS  Google Scholar 

  151. Turny F, Jedynak P, Agid Y. Athetosis or dystonia? Rev Neurol (Paris). 2004;160:759–64.

    Article  CAS  Google Scholar 

  152. Morris JG, et al. Athetosis II: the syndrome of mild athetoid cerebral palsy. Mov Disord. 2002;17(6):1281–7.

    Article  PubMed  Google Scholar 

  153. Morris JG, et al. Athetosis I: historical considerations. Mov Disord. 2002;17(6):1278–80.

    Article  PubMed  Google Scholar 

  154. Nygaard TG, Duvoisin RC. Hereditary dystonia-parkinsonism syndrome of juvenile onset. Neurology. 1986;36(11):1424–8.

    Article  PubMed  CAS  Google Scholar 

  155. Wein T, et al. Exquisite sensitivity of paroxysmal kinesigenic choreathetosis to carbamazepine. Neurology. 1996;47:1104–6.

    Article  PubMed  CAS  Google Scholar 

  156. Micheli F, et al. Paroxysmal dystonia responsive to anticholinergic drugs. Clin Neuropharmacol. 1987;10:365–9.

    Article  PubMed  CAS  Google Scholar 

  157. Shibasaki H, et al. Electroencephalographic correlates of myoclonus. Adv Neurol. 1986;43:357–72.

    PubMed  CAS  Google Scholar 

  158. Shibasaki H. Electrophysiological studies of myoclonus. Muscle Nerve. 2000;23(3):321–35.

    Article  PubMed  CAS  Google Scholar 

  159. Lance J, Adams R. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain. 1963;86:111.

    Article  PubMed  CAS  Google Scholar 

  160. Asmus F, Gasser T. Inherited myoclonus-dystonia. Adv Neurol. 2004;94:113–9.

    PubMed  Google Scholar 

  161. Lang AE. Essential myoclonus and myoclonic dystonia. Mov Disord. 1997;12(1):127.

    Article  PubMed  CAS  Google Scholar 

  162. Dooley JM, Hayden JD. Benign febrile myoclonus in childhood. Can J Neurol Sci. 2004;31:504–5.

    PubMed  CAS  Google Scholar 

  163. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol. 1962;25:271.

    CAS  Google Scholar 

  164. Warrier RP, et al. Opsomyoclonus and neuroblastoma. Clin Pediatr (Phila). 1985;24(1):32–4.

    Article  CAS  Google Scholar 

  165. Connolly AM, et al. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr. 1997;130(6):878–84.

    Article  PubMed  CAS  Google Scholar 

  166. Tate ED, et al. Neuroepidemiologic trends in 105 US Cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs. 2005;22(1):8–19.

    Article  PubMed  Google Scholar 

  167. Sheth RD, et al. Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection. J Child Neurol. 1995;10(4):297–9.

    Article  PubMed  CAS  Google Scholar 

  168. Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord. 1996;11(2):119–24.

    Article  PubMed  CAS  Google Scholar 

  169. Fahn S, Sjaastad O. Hereditary essential myoclonus in a large Norwegian family. Mov Disord. 1991;6(3):237–47.

    Article  PubMed  CAS  Google Scholar 

  170. Shibasaki H, Hallett M. Electrophysiological studies of myoclonus. Muscle & Nerve. 2005;31(2):157–174.

    Google Scholar 

  171. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol. 2004;3(10):598–607.

    Article  PubMed  Google Scholar 

  172. Furukawa Y, Rajput AH. Inherited myoclonus-dystonia: how many causative genes and clinical phenotypes? Neurology. 2002;59(8):1130–1.

    Article  PubMed  Google Scholar 

  173. Schule B, et al. Genetic heterogeneity in ten families with myoclonus-dystonia. J Neurol Neurosurg Psychiatry. 2004;75(8):1181–5.

    Article  PubMed  CAS  Google Scholar 

  174. Valente EM, et al. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord. 2003;18(9):1047–51.

    Article  PubMed  Google Scholar 

  175. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2–23.

    Google Scholar 

  176. Makabe H, Sakamoto K. Evaluation of postural tremor of finger for neuromuscular diseases and its application to the classification. Electromyogr Clin Neurophysiol. 2002;42(4):205–18.

    PubMed  CAS  Google Scholar 

  177. Takanokura M, Kokuzawa N, Sakamoto K. The origins of physiological tremor as deduced from immersions of the finger in various liquids. Eur J Appl Physiol. 2002;88(1–2):29–41.

    Article  PubMed  Google Scholar 

  178. Elble RJ. Essential tremor frequency decreases with time. Neurology. 2000;55(10):1547–51.

    Article  PubMed  CAS  Google Scholar 

  179. Findley LJ, Gresty MA, Halmagyi GM. Tremor, the cogwheel phenomenon and clonus in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1981;44(6):534–46.

    Article  PubMed  CAS  Google Scholar 

  180. O’Suilleabhain PE, Matsumoto JY. Time-frequency analysis of tremors. Brain. 1998;121(11):2127–34.

    Article  PubMed  Google Scholar 

  181. Kim YJ, Pakiam AS, Lang AE. Historical and clinical features of psychogenic tremor: a review of 70 cases. Can J Neurol Sci. 1999;26(3):190–5.

    PubMed  CAS  Google Scholar 

  182. Zeuner KE, et al. Accelerometry to distinguish psychogenic from essential or parkinsonian tremor. Neurology. 2003;61(4):548–50.

    Article  PubMed  CAS  Google Scholar 

  183. Leung GK, Fan YW, Ho SL. Rubral tremor associated with cavernous angioma of the midbrain. Mov Disord. 1999;14(1):191–3.

    Article  PubMed  CAS  Google Scholar 

  184. Tan H, et al. Rubral tremor after thalamic infarction in childhood. Pediatr Neurol. 2001;25(5):409–12.

    Article  PubMed  CAS  Google Scholar 

  185. Stremmel W, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115(9):720–6.

    PubMed  CAS  Google Scholar 

  186. Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987;146(3):261–5.

    Article  PubMed  CAS  Google Scholar 

  187. Louis ED, Dure LS IV, Pullman S. Essential tremor in childhood: a series of nineteen cases. Mov Disord. 2001;16(5):921–3.

    Google Scholar 

  188. Jankovic J, Madisetty J, Vuong KD. Essential tremor among children. Pediatrics. 2004;114(5):1203–5.

    Article  PubMed  Google Scholar 

  189. Paulson GW. Benign essential tremor in childhood: symptoms, pathogenesis, treatment. Clin Pediatr (Phila). 1976;15(1):67–70.

    Article  CAS  Google Scholar 

  190. Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology. 2004;62(6):932–6.

    Article  PubMed  Google Scholar 

  191. Gironell A, et al. A randomized placebo-controlled comparative trial of gabapentin and ­propranolol in essential tremor. Arch Neurol. 1999;56(4):475–80.

    Article  PubMed  CAS  Google Scholar 

  192. Yuill GM. Suppression of “rubral” tremor with levodopa. Br Med J. 1980;281(6252):1428.

    Article  PubMed  CAS  Google Scholar 

  193. Findley LJ, Gresty MA. Suppression of “rubral” tremor with levodopa. Br Med J. 1980;281(6247):1043.

    Article  PubMed  CAS  Google Scholar 

  194. Jacob PC, Pratap Chand R. Posttraumatic rubral tremor responsive to clonazepam. Mov Disord. 1998;13(6):977–8.

    Article  PubMed  CAS  Google Scholar 

  195. Nikkhah G, et al. Deep brain stimulation of the nucleus ventralis intermedius for Holmes (rubral) tremor and associated dystonia caused by upper brainstem lesions. Report of two cases. J Neurosurg. 2004;100(6):1079–83.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Engineering, Child Neurology, and Biokinesiology, University of Southern California, 1042 Downey Way, Los Angeles, CA, 90089, USA

    Terence D. Sanger MD, PhD

Authors
  1. Terence D. Sanger MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Terence D. Sanger MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Medicine (Neurology) and Medical Genetics, University of Alberta, Edmonton, AB, Canada

    Oksana Suchowersky

  2. Department of Neurology, Rush University Medical Center, Chicago, IL, USA

    Cynthia Comella

Electronic Supplementary material

CASE 1 - Dystonia (mp4 10,912 KB)

CASE 2 - Myoclonus - Ataxia (mp4 6,420 KB)

CASE 3 - Generalized Hyperkinetic Movements (mp4 21,216 KB)

CASE 4 - Chin Tremor (mp4 1,626 KB)

CASE 5 - Rett Syndrome (mov 178,378 KB)

CASE 6 - Tremor / Dystonia (mov 12,571 KB)

CASE 6 - Tremor / Dystonia (mov 5,713 KB)

CASE 7 - Myoclonus (mp4 11,340 KB)

CASE 8 - Generalized Choreoathetosis (mov 83,524 KB)

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sanger, T.D. (2012). Hyperkinetic Disorders in Childhood. In: Suchowersky, O., Comella, C. (eds) Hyperkinetic Movement Disorders. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-120-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-120-2_9

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-805-8

  • Online ISBN: 978-1-60327-120-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation